These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33137682)

  • 1. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.
    Oliveira KM; Honorato J; Demidoff FC; Schultz MS; Netto CD; Cominetti MR; Correa RS; Batista AA
    J Inorg Biochem; 2021 Jan; 214():111289. PubMed ID: 33137682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer.
    Oliveira KM; Peterson EJ; Carroccia MC; Cominetti MR; Deflon VM; Farrell NP; Batista AA; Correa RS
    Dalton Trans; 2020 Nov; 49(45):16193-16203. PubMed ID: 32329497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells.
    De Grandis RA; Santos PWDSD; Oliveira KM; Machado ART; Aissa AF; Batista AA; Antunes LMG; Pavan FR
    Bioorg Chem; 2019 Apr; 85():455-468. PubMed ID: 30776556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-melanoma effect of ruthenium(II)-diphosphine complexes containing naphthoquinone ligand.
    Rinaldi-Neto F; Ribeiro AB; Ferreira NH; Squarisi IS; Oliveira KM; Orenha RP; Parreira RLT; Batista AA; Tavares DC
    J Inorg Biochem; 2021 Sep; 222():111497. PubMed ID: 34090039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis.
    Oliveira KM; Liany LD; Corrêa RS; Deflon VM; Cominetti MR; Batista AA
    J Inorg Biochem; 2017 Nov; 176():66-76. PubMed ID: 28865744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparasitic activities of novel ruthenium/lapachol complexes.
    Barbosa MI; Corrêa RS; de Oliveira KM; Rodrigues C; Ellena J; Nascimento OR; Rocha VP; Nonato FR; Macedo TS; Barbosa-Filho JM; Soares MB; Batista AA
    J Inorg Biochem; 2014 Jul; 136():33-9. PubMed ID: 24727183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
    Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the potential of ruthenium(II)-phosphine-mercapto complexes as new anticancer agents.
    Palmeira-Mello MV; Costa AR; de Oliveira LP; Blacque O; Gasser G; Batista AA
    Dalton Trans; 2024 Jul; 53(26):10947-10960. PubMed ID: 38895770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents.
    De Grandis RA; Costa AR; Moraes CAF; Sampaio NZ; Cerqueira IH; Marques WG; Guedes APM; de Araujo-Neto JH; Pavan FR; Demidoff FC; Netto CD; Batista AA; Resende FA
    J Inorg Biochem; 2022 Dec; 237():112005. PubMed ID: 36155170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation.
    Cunha BN; Luna-Dulcey L; Plutin AM; Silveira RG; Honorato J; Cairo RR; de Oliveira TD; Cominetti MR; Castellano EE; Batista AA
    Inorg Chem; 2020 Apr; 59(7):5072-5085. PubMed ID: 32208661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.
    Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA
    J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium complexes show promise when submitted to toxicological safety tests using alternative methodologies.
    Teixeira TM; Arraes IG; Abreu DC; Oliveira KM; Correa RS; Batista AA; Braunbeck T; de Paula Silveira Lacerda E
    Eur J Med Chem; 2021 Apr; 216():113262. PubMed ID: 33711764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo.
    da Silva MM; Ribeiro GH; de Camargo MS; Ferreira AG; Ribeiro L; Barbosa MIF; Deflon VM; Castelli S; Desideri A; Corrêa RS; Ribeiro AB; Nicolella HD; Ozelin SD; Tavares DC; Batista AA
    Inorg Chem; 2021 Sep; 60(18):14174-14189. PubMed ID: 34477373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Half-Sandwich Ru(
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Fernandes AR; Roma-Rodrigues C; Teixeira RG; Marques F; Folgueira M; Yáñez J; Gonzalez AA; Salamini-Montemurri M; Pech-Puch D; Vázquez-García D; Torres ML; Fernández A; Fernández JJ
    Inorg Chem; 2021 Mar; 60(5):2914-2930. PubMed ID: 33570919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ru(II)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells.
    Oliveira KM; Honorato J; Gonçalves GR; Cominetti MR; Batista AA; Correa RS
    Dalton Trans; 2020 Sep; 49(36):12643-12652. PubMed ID: 32870224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes.
    Velozo-Sá VS; Pereira LR; Lima AP; Mello-Andrade F; Rezende MRM; Goveia RM; Pires WC; Silva MM; Oliveira KM; Ferreira AG; Ellena J; Deflon VM; Grisolia CK; Batista AA; Silveira-Lacerda EP
    Dalton Trans; 2019 May; 48(18):6026-6039. PubMed ID: 30724926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
    Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
    Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether).
    Grawe GF; Oliveira KM; Leite CM; de Oliveira TD; Costa AR; Moraes CAF; Honorato J; Cominetti MR; Castellano EE; Correa RS; Machado SP; Batista AA
    J Inorg Biochem; 2023 Jul; 244():112204. PubMed ID: 37004320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
    Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
    J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction.
    Ribeiro GH; Guedes APM; de Oliveira TD; de Correia CRSTB; Colina-Vegas L; Lima MA; Nóbrega JA; Cominetti MR; Rocha FV; Ferreira AG; Castellano EE; Teixeira FR; Batista AA
    Inorg Chem; 2020 Oct; 59(20):15004-15018. PubMed ID: 32997499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.